Preclinical target validation using patient-derived cells
Nature Reviews Drug Discovery2015Vol. 14(3), pp. 149–150
Citations Over TimeTop 10% of 2015 papers
A.M. Edwards, C.H. Arrowsmith, C. Bountra, Mark E. Bunnage, Marc Feldmann, Julian C. Knight, Dhavalkumar D. Patel, Panagiotis Prinos, Michael D. Taylor, M. Sundström, Phil Barker, Dalia Barsyte, Mário Henrique Bengtson, Cindy Bell, Paul Bowness, Kym M. Boycott, Carolyn Buser‐Doepner, Christopher L. Carpenter, Andrew Carr, Kirk Clark, Anuk Das, Dashyant Dhanak, Peter B. Dirks, James Ellis, Valeria R. Fantin, Christopher M. Flores, Edward A. Fon, Donald E. Frail, O. Gileadi, Rónán C. O’Hagan, Trevor Howe, John Isaac, Nada Jabado, Per‐Johan Jakobsson, Lars Klareskog, Stefan Knapp, Wen‐Hwa Lee, Evelyne Lima‐Fernandes, Ingrid E. Lundberg, John C. Marshall, Katlin B. Massirer, Alex MacKenzie, Tetsuyuki Maruyama, Anke Mueller‐Fahrnow, Senthil K. Muthuswamy, Jagdeep Nanchahal, Catherine O′Brien, Udo Oppermann, Nils Ostermann, Kevin Petrecca, Bruce G. Pollock, Viviane Poupon, Rab K. Prinjha, Saul H. Rosenberg, Guy A. Rouleau, Malcolm Skingle, Arthur S. Slutsky, G. Smith, Dominique Verhelle, Hans Widmer, L. Trevor Young
Related Papers
- → The future of precision medicine: towards a more predictive personalized medicine(2020)63 cited
- → Genomic medicine on the frontier of precision medicine(2021)18 cited
- → Precíziós és perszonalizált medicina(2016)1 cited
- Establishing research-based hospital to promote translational medicine development(2009)
- Dynamic Analysis of Translational Medicine Development of in Hospitals in China(2014)